You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

Assessment and Classification of Disease Prognosis

Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment and classification of disease prognosis at least once within 12 months.

Date Reviewed: April 27, 2015

Measure Info

MIPS 179CMS 179
Measure Type: 
Process
Measure Steward: 
American College of Rheumatology
Clinical Topic Area: 
Rheumatoid Arthritis

Care Setting: 
Outpatient
Data Source: 
Registry

ACP does not support PQRS 179: “Assessment and Classification of Disease Prognosis.” ACP does not support this measure because there is no evidence supporting annual frequency or describing appropriate frequency for assessment or classification of disease prognosis. Additionally, it seems unnecessary to reassess prognosis annually if a poor prognosis has been established based on factors that will not change such as high titer anti-citric citrullinated peptide (anti-CCP) antibodies, rheumatoid factor (RF) or radiographic erosions.

As part of an ongoing effort to improve user experience, we have made some updates to the Performance Measures section of ACP. Tell us what you think!